Anticancer agent 189
Anticancer agent 189 (compound 4) is an anticancer agent that antagonizes CRC effects by targeting AKT1[1].
Product Specifications
CAS Number
9007-83-4
UNSPSC
12352005
Target
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-189.html
Solubility
10 mM in DMSO
Smiles
O=C(N[C@H](C(O[C@@H]([C@@H](/C=C/C=C([C@H](OC)C[C@H](O1)[C@]1(C)C(N([C@H]2[C@](CC)(C)[H])C)=O)\C)C)C3=CC=CC=C3)=O)C(C)(O)C)[C@H](NC2=O)CC4=CC=C([N+]([O-])=O)C=C4
Molecular Formula
C42H56N4O10
Molecular Weight
776.91
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal TULA/STS-2 Antibody [DyLight 594]](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
NBP3-00200DL594 0.1 mL
Rabbit Polyclonal TULA/STS-2 Antibody [DyLight 594]
Sign In for Pricing
View Details 
